Key Statistics
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Analyst Ratings
View All →| Date | Firm | Rating |
|---|---|---|
| Feb 3, 2026 | RBC Capital | |
| Jan 28, 2026 | Morgan Stanley | |
| Jan 27, 2026 | Freedom Capital Markets | |
| Jan 23, 2026 | Guggenheim | |
| Jan 22, 2026 | Scotiabank |